United States · 
What does Treo Ventures invest in?
Treo Ventures invests most often at Series A and Series B (67% of the rounds on record), in sectors such as Sustainability, Underserved and Bioimaging.
Treo Ventures highlights
- 01
6 rounds on record
- 02
Mostly Series A and Series B: 67% of its rounds
- 03
Led 2 rounds
What they do
We focus on medical device and digital health innovation that can significantly impact human life. We invest in companies based in US and Europe through our offices located in Silicon Valley and Ireland.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- Series ASeries BGrowth
- Sectors
- SustainabilityUnderservedBioimaging
- Based in
- Santa Clara, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first6 appearances
- 2025
2 rounds
- Oct
- Apr
- 2024
4 rounds
- Oct
- Jul
- Apr
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
BKBrad K. ValeA Managing Member of the General PartneriFiling they signed
MKMudit K. JainA Managing Member of the General PartneriFiling they signed
We also hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$195Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- TREO Ventures, LLC
- SEC number
- CRD 299417
What they claim to have backed
From their own portfolio page (on their website)
7 of 10 we have independently watched raise
AvivomedIveacareNeochordNeusperaNoctrixhealthPresspogoShiratronicsIntervene-medNuxcelSecondwaveus
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.